Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07572513
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue UniversityRecruitingNot Applicable
NCT07572513Recruiting
Not Applicable
Slowly Digestible Carbohydrates for GLP-1 SecretionPurdue University
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07574346
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People's HospitalNot Yet RecruitingEarly Phase 1
NCT07574346Not Yet Recruiting
Early Phase 1
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People'...
NCT07573124
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechanical Lumbar Traction in Lumbar RadiculopathyKhyber Medical University PeshawarRecruitingNot Applicable
NCT07573124Recruiting
Not Applicable
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechani...Khyber Medical University...
NCT07572071
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's DiseaseIran University of Medical SciencesRecruitingPhase 1
NCT07572071Recruiting
Phase 1
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Park...Iran University of Medica...
NCT07573579
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest Hospital NHS Foundation TrustNot Yet RecruitingNot Applicable
NCT07573579Not Yet Recruiting
Not Applicable
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest...
NCT07573683
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive IndividualsFoundation University IslamabadRecruitingNot Applicable
NCT07573683Recruiting
Not Applicable
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary...Foundation University Isl...
NCT07573618
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration Versus Standard AnticoagulationWeiwei WuNot Yet RecruitingNot Applicable
NCT07573618Not Yet Recruiting
Not Applicable
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration V...Weiwei Wu
NCT07573085
Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA) With Self-injury Within Child and Adolescent Mental Health ServicesKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07573085Not Yet Recruiting
Not Applicable
Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA)...Karolinska Institutet
NCT07573943
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus InfectionFirst Affiliated Hospital of Chongqing Medical UniversityRecruitingPhase 4
NCT07573943Recruiting
Phase 4
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chron...First Affiliated Hospital...
NCT07573514
Patients With Primary Biliary CholangitisFondazione Policlinico Universitario Agostino Gemelli IRCCSActive Not RecruitingNot Applicable
NCT07573514Active Not Recruiting
Not Applicable
Patients With Primary Biliary CholangitisFondazione Policlinico Un...
NCT07572058
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLCNot Yet RecruitingNot Applicable
NCT07572058Not Yet Recruiting
Not Applicable
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLC
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574190
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South DakotaNot Yet RecruitingNot Applicable
NCT07574190Not Yet Recruiting
Not Applicable
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South Dakot...
NCT07572292
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine PositionVrije Universiteit BrusselNot Yet RecruitingNot Applicable
NCT07572292Not Yet Recruiting
Not Applicable
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine Po...Vrije Universiteit Brusse...
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573488
Sleep, Stress and Migraine - an Observational and Training StudySusanne WegenerRecruitingNot Applicable
NCT07573488Recruiting
Not Applicable
Sleep, Stress and Migraine - an Observational and Training StudySusanne Wegener
Result Breakdown
Not yet recruiting11 (55%)
Recruiting7 (35%)
Unknown1 (5%)
Active, not recruiting1 (5%)
not_applicable14 (70%)
Phase 22 (10%)
Not Specified1 (5%)
Early Phase 11 (5%)
Phase 11 (5%)
Phase 41 (5%)